ArticleCancer immunology, immunotherapy : CII2025

Be cautious to adopt a second CAR T-cell infusion after failure of CD19/CD22 cocktail CAR T-cell therapy in relapsed/refractory B-NHL.

Gaoxiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.